Covering: up to 2010 This review focuses on recent developments in the use of natural
products as therapeutics for Alzheimer's disease. The compounds span a diverse array of …

Dementia is a clinical syndrome of widespread progressive deterioration of cognitive
abilities and normal daily functioning. These cognitive and behavioral impairments pose …

One of the most widely used guides to prescribing psychiatric medications, the Tenth Edition
of Maudsley Prescribing Guidelines returns with fully updated content and new sections on …

Currently available treatments have limited pro-cognitive effects for neuropsychiatric
disorders, such as schizophrenia, Parkinson's disease and Alzheimer's disease. The …

Dementia pathologies such as Alzheimer's disease (AD) are reaching epidemic proportions,
yet they are not successfully managed by effective symptomatic treatments. Only five drugs …

Background: Medications are frequently prescribed for neuropsychiatric symptoms (NPS)
associated with dementia, although information on the efficacy and safety of medications for …

Abstract Affecting over 100,000 older Missourians, cognitive impairment is of concern for all
health care providers. With no available pharmacologic treatments to eradicate/diminish …

Activators of M1 muscarinic acetylcholine receptors (mAChRs) may provide novel treatments
for schizophrenia and Alzheimer's disease. Unfortunately, the development of M1-active …

Objectives To examine racial and ethnic differences in initiation and time to discontinuation
of antidementia medication in Medicare beneficiaries. Design Retrospective cohort study …

Background: Quality of life (QOL) is increasingly recognized as the main target of currently
available dementia care. Its assessment has grown exponentially in the dementia field, but …